FIELD: medicine, pharmacy. SUBSTANCE: invention relates to application of colostrinin as a drug in treatment of chronic disorders of central nervous system, immune system, neurological, mental disorders, feeble-mindedness, neurodegenerative diseases, Alzheimer's disease, motoneuron disease, for treatment of psychosis or neurosis as a dietetic supplement. Invention relates also to pharmaceutical composition containing colostrinin, dietetic supplement and nanopeptide. Invention provides the realization of indicated designation. EFFECT: valuable medicinal properties of drug. 24 cl, 3 tbl, 1 dwg, 10 ex
Authors
Dates
2003-11-27—Published
1997-10-03—Filed